News | Gastrointestinal system diseases

Letter

Specialist pharmacy services must be put in place for patients with IBD

The views expressed in this letter are those of the author’s. If you would like to submit a letter to The Pharmaceutical Journal, please click here. An article published by The Pharmaceutical Journal in April 2021 states correctly that, of the nearly 200 inflammatory bowel disease (I…

Published: 9 July 2021

News

Only 13% of IBD teams meet standards for pharmacist involvement

A report by IBD UK, an alliance of professional bodies, has found that few inflammatory bowel disease services in the UK have enough expert pharmacists.…

Published: 28 April 2021

News

Shortages of alternatives to ranitidine could be putting patients at risk

Pharmacists have reported supply issues with the recommended alternatives to ranitidine, which has been suspended owing to the presence of the contaminant N-Nitrosodimethylamine.…

Published: 6 April 2021

Opinion

Top five infographics of 2020

I’m sure it will come as no surprise that The Pharmaceutical Journal’s most-read infographics this year take a look at COVID-19.…

Published: 22 December 2020

Opinion

What my rollercoaster ride with ‘long COVID’ has taught me about being a pharmacist

At 30 years of age, advanced pharmacist Geraint Jones never imagined a virus could hit him so hard — here, he shares his devastating account of how ‘long COVID’ has affected him, both personally and professionally.…

Published: 16 December 2020

News

‘Patients want a fresh start without the stigma’ – a day in the life of an HIV and gastroenterology pharmacist

Akwasi Mintah details a typical day providing pharmaceutial care to patients with HIV and inflammatory bowel disease.…

Published: 16 November 2020

Infographic

Untangling IBS from IBD

Although they sound similar, share some symptoms and are not mutually exclusive, irritable bowel syndrome and inflammatory bowel disease are two distinct conditions that require different approaches.…

Published: 29 October 2020

News

Regular use of PPIs linked with increased risk of type 2 diabetes, study suggests

Regular use of proton-pump inhibitors increases patients’ risk of developing type 2 diabetes mellitus by 24%, an observational study published in Gut has suggested.…

Published: 29 September 2020

News

Medicines regulator introduces age restrictions on OTC laxatives following safety review

Over-the-counter laxatives for adolescents aged 12 to 17 years can now only be supplied under the supervision of a pharmacist, following the results of a review by the Medicines and Healthcare products Regulatory Agency.…

Published: 18 August 2020

News

Inflammatory bowel disease may be linked to increased risk of dementia

People with inflammatory bowel disease have a significantly higher risk of developing dementia later in life, a study in Gut has suggested.…

Published: 29 June 2020